Filter Results:
(3,188)
Show Results For
- All HBS Web
(3,188)
- People (7)
- News (425)
- Research (2,383)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,960)
Show Results For
- All HBS Web
(3,188)
- People (7)
- News (425)
- Research (2,383)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,960)
- 25 Apr 2017
- First Look
First Look at New Research, April 25
ReVista: Harvard Review of Latin America Globalizing Latin American Beauty By: Jones, G. Abstract—This article discusses the growth over time of the beauty industry in Latin America and its bias towards celebrating whiter rather than... View Details
Keywords: Sean Silverthorne
- 02 Jun 2021
- News
HBS Announces 2021-22 Blavatnik Fellows
provides mentorship during their entrepreneurial journey. To date, Blavatnik Fellows have created 26 companies in biomedical industries including devices, diagnostics, digital health, and therapeutics, and have collectively raised more... View Details
- November 2024
- Teaching Note
Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams
By: Debora L. Spar and Julia M. Comeau
Teaching Note for HBS Case No. 323-039. In 1990, satellite expert and Sirius XM founder Martine Rothblatt was determined to save the life of her seven-year-old daughter, Jenesis, who was diagnosed with a terminal illness called Pulmonary Arterial Hypertension (PAH). At... View Details
Keywords: Pharmaceutical Companies; Technological And Scientific Innovation; Organ Donation; Health Care and Treatment; Health Disorders; Innovation and Invention; Growth and Development Strategy; Product Development; Pharmaceutical Industry; Pharmaceutical Industry; United States; District of Columbia
- 01 Jun 2004
- News
The Inner-City Advantage
African-American Student Union. Growing opportunities and competitive advantages have made the inner city a hot spot for investors, particularly developers. “Real estate is a $24 trillion industry — there’s no bubble there,” said Yvonne... View Details
- Profile
Vivian Scalfi
market research stint and five years with General Electric, where she progressed through the commercial leadership rotational program in health care, oil and gas, and power, Vivian shifted into consumer goods with a role at Diageo... View Details
Keywords: CPG
- February 2006 (Revised February 2009)
- Case
AIDS in Brazil
By: Rohit Deshpande and Ricardo Reisen de Pinho
Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra. View Details
Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil
Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2006. (Revised February 2009.)
- 25 Aug 2022
- News
Ready for Departure
accelerate construction projects. And now, finally, travel plans are back on. Here, alumni from the field share insights into how the industry has readied itself for your arrival at the airport—and what to expect in the next era of travel... View Details
- 01 Oct 2002
- News
Making a Difference
the globe to put their skills to work on issues related to the environment, education, the arts, health care, poverty, and economic development. In the United States, fellows worked in diverse organizations such as the National Campaign... View Details
- 11 Sep 2007
- First Look
First Look: September 11, 2007
European private equity industry as of mid-1998. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=299017 PublicationsThe CEO Within: Why Inside Outsiders Are the Key to Succession Planning Author:Joseph... View Details
Keywords: Martha Lagace
- April 2011 (Revised March 2012)
- Supplement
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
By: Arthur A. Daemmrich
Supplement to "U.S. Healthcare Reform: International Perspectives" updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Political Elections; Health Care and Treatment; Lawsuits and Litigation; Business and Government Relations; Public Opinion; Health Industry; Health Industry; United States
Daemmrich, Arthur A. "U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010." Harvard Business School Supplement 711-103, April 2011. (Revised March 2012.)
- 14 Feb 2019
- News
Plotting a Path Forward on Climate Change
microorganisms that improve crop health and productivity, reducing the need for chemical fertilizers and pesticides. “We could absorb all the carbon humans have put into the atmosphere since the beginning of the View Details
- June 1990 (Revised June 2004)
- Teaching Note
Nestle Alimentana S.A. -- Infant Formula (Abridged) TN
By: James E. Austin and Tomas Otto Kohn
Teaching Note for (9-590-070). View Details
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- Working Paper
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
By: Pragya Kakani, Michael Chernew and Amitabh Chandra
Rising list prices are often used to illustrate the burden of prescription drug spending, but payers routinely negotiate rebates from manufacturers that generate differences between list and net prices. List prices are easily available and affect patient cost-sharing,... View Details
Keywords: Pharmaceuticals; Rebates; Health Care and Treatment; Markets; Price; Analysis; Pharmaceutical Industry
Kakani, Pragya, Michael Chernew, and Amitabh Chandra. "Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S." NBER Working Paper Series, No. 26846, March 2020.
- November 1999
- Supplement
"ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995
Provides excerpts from an interview with Peter Staley of Act Up reflecting on the Wall Street protest against Burroughs Wellcome in the fall of 1989 and on the role and impact of AIDS advocacy and activism in general. View Details
Emmons, Willis M., III. "ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995. Harvard Business School Video Supplement 700-501, November 1999.
- 2018
- Working Paper
Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices
By: Prithwiraj Choudhury and Tarun Khanna
We exploit a natural experiment to study how codifying information about prior innovation affects subsequent innovation. A codified database of traditional Indian herbal formulations was adopted by the European Patent Office (EPO) and the U.S. Patent and Trademark... View Details
Keywords: Patents; Plant-Based Agribusiness; Ethnicity; Health Care and Treatment; Pharmaceutical Industry; Pharmaceutical Industry; China; India
Choudhury, Prithwiraj, and Tarun Khanna. "Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices." Harvard Business School Working Paper, No. 14-079, February 2014. (Revised January 2018.)
- 05 Jan 2016
- News
Alumni Top Two New Lists of Rising Stars
cofounder of RubiconMD, an online venture that allows primary-care doctors to consult with specialists online. Michael Belkin (MBA 2012), CEO and cofounder of Distinc.tt, a social network for the LGBT community. Adam Besvinick (MBA 2013), principal in Deep Fork Capital... View Details
- May 16, 2016
- Article
Food Safety Economics: The Cost of a Sick Customer
By: Dina Gerdeman and John A. Quelch
Chipotle Mexican Grill’s ongoing struggle to win customers back months after a contaminated food crisis highlights the challenges companies face with keeping food safe.
Chipotle has seen its shares tumble and recently reported its first-ever quarterly loss... View Details
Chipotle has seen its shares tumble and recently reported its first-ever quarterly loss... View Details
Keywords: Food Safety; Organic Food; Supply Chain Management; Globalization Of Food Business; Mérieux NutriSciences: Marketing Food Safety Testing; Food Safety Modernization Act 2011; Plant-Based Agribusiness; Transition; Economic Systems; Food; Health; Supply and Industry; Logistics; Practice; Problems and Challenges; Quality; Safety; Business Strategy; Corporate Strategy; Customization and Personalization; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Mexico; North America; United States; Canada
Gerdeman, Dina, and John A. Quelch. "Food Safety Economics: The Cost of a Sick Customer." Harvard Business School Working Knowledge (May 16, 2016).
- Web
Student Clubs | MBA
Family Business Club Finance Club FinTech Club First Generation Students Club Food and Agriculture Club Football/Soccer Club Formula One Club French-Speaking Club Future of Mobility Future of Work Club G Gaming and Game Industry Club... View Details
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
talking with industry experts and reading the literature, Luo and Galasso found that companies had known for a long time about the potential for dose-reducing technology, but had not developed it due to lack of demand. “It seems that the... View Details